中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Postoperative and Opioid Free Anesthesia

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态已终止
赞助商
Rennes University Hospital

关键词

抽象

Since the 1960's, intraoperative administration of opioids is considered a keystone of anesthesia as well as hypnotics and muscle relaxants. Synthetic opioids were introduced to achieve hemodynamic stability during anesthesia. They allow an inhibition of the sympathetic system without cardiovascular collapse and histamine release. Since then, anesthesia has changed from inhalation to multimodal anesthesia with lower doses of hypnotic. In 2017, the intraoperative objectives of hypnosis, hemodynamic stability, immobility and anticipation of postoperative analgesia can be achieved without opioids. Moreover, opioid administration consequences are neither scarce nor benign for the patient. Perioperative opioids are associated with nausea and vomiting, sedation, ileus, confusion/delirium, respiratory depression, increased postoperative pain and morphine consumption, immunodepression, hyperalgesia and chronic postoperative pain. Among these complications, hypoxemia, ileus and confusion/delirium are the most frequent.
Efficacious multimodal analgesia and anesthesia are the basis of successful fast-track surgery. These multidrug regimens aim at decreasing postoperative pain, intra- and postoperative opioid requirements, and subsequently, opioid-related adverse effects and to fasten recovery. Opioid-free postoperative analgesia has been recommended for more than 10 years. Opioid-free anesthesia (OFA) is based on the idea that hemodynamic stability can be achieved without opioids during anesthesia. OFA is multimodal anesthesia associating hypnotics, N-methyl-D-aspartate (NMDA) antagonists, local anesthetics, anti-inflammatory drugs and alpha-2 agonists (Dexmedetomidine).
Proofs of the effect of OFA on reducing opioid-related adverse effects after major or intermediate non-cardiac surgery are still scarce. We hypothesized that the reduced opioid consumption during and after surgery allowed by OFA compared with standard of care will be associated with a reduction of postoperative opioid-related adverse events.

日期

最后验证: 09/30/2019
首次提交: 10/12/2017
提交的预估入学人数: 10/18/2017
首次发布: 10/19/2017
上次提交的更新: 10/15/2019
最近更新发布: 10/17/2019
实际学习开始日期: 11/28/2017
预计主要完成日期: 01/28/2019
预计完成日期: 06/18/2019

状况或疾病

Anesthesia
Opioid-Related Disorders

干预/治疗

Drug: Dexmedetomidine

Drug: Control

相 3

手臂组

干预/治疗
Experimental: Dexmedetomidine
Drug: Dexmedetomidine
Opioid-free anesthesia
Active Comparator: Control
Drug: Control
Opioid anesthesia

资格标准

有资格学习的年龄 18 Years 至 18 Years
有资格学习的性别All
接受健康志愿者
标准

Inclusion Criteria:

- Undergoing a scheduled major or intermediate non-cardiac surgery,

- Benefiting from the health insurance system,

- Having signed an informed consent.

Exclusion Criteria:

- Pregnant or breast feeding women,

- Allergy to dexmedetomidine or one of its excipients,

- Allergy to one of the drugs used for anesthesia or one of their excipients,

- Urgent surgery,

- Intracranial surgery,

- Transplant surgery or transplanted patients,

- Surgery with planned regional anesthesia,

- Outpatient surgery,

- Atrioventricular block, intraventricular or sinoatrial block,

- Treatment by chronic betablockers and HR < 50 bpm,

- Heart failure with LVEF < 40%,

- Adam-Stokes syndrome,

- Epilepsy or seizures,

- Uncontrolled hypotension,

- Acute cerebral pathology,

- Obstructive sleep apnea syndrome,

- Severe hepatic insufficiency (Prothrombin Ratio < 15%),

- Patients in whom the CAM-ICU cannot be performed (deaf patients for example)

- Adults legally protected (under judicial protection, guardianship, or supervision), persons deprived of their liberty.

结果

主要结果指标

1. Occurence of a severe postoperative opioid-related adverse event defined as : postoperative hypoxemia or postoperative ileus (POI) or postoperative cognitive dysfunction (POCD). [Within the first 48 hours after extubation]

Postoperative hypoxemia is defined as an oxygen saturation (SpO2) < 95% with a need for oxygen supplementation within the first 48h after extubation; the duration of oxygen treatment will also be recorded. Postoperative ileus is defined as an absence of flatus or stools within the first 48h after extubation. Postoperative cognitive dysfunction will be evaluated using the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) by a care provider (either anesthesiologist or nurse).

次要成果指标

1. Number of episodes of postoperative pain (numeric rating scale ≥ 3), at rest [Within 48 hours after extubation]

2. Opioid consumption [During the 48 hours following extubation]

3. Time between the end of remifentanil or dexmedetomidine administration and an Aldrete score > 9 (when applicable) [Within 48 hours after extubation]

4. Time between the end of remifentanil or dexmedetomidine administration and extubation [Hour 0 = extubation]

5. Rate of unscheduled admission in intensive care unit [Within 48 hours after extubation]

6. Number of postoperative nausea and vomiting (PONV) episodes [During the 48 hours following extubation]

7. Hospital length of stay (max 28 days) defined as the number of days after extubation before first hospital discharge [Day 28]

8. Number of bradycardia, hypotension and hypertension events during surgery and number of rescue medications during surgery [During surgery (maximum duration of 7 hours)]

Bradycardia is defined as the number of episodes with atropine administration. Hypotension is defined as mean arterial blood pressure < 65 mmHg. Hypertension is defined as mean arterial blood pressure > 90 mmHg.

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge